What is Brigham/Faulkner Ob/Gyn?
Brigham/Faulkner Ob/Gyn operates as a specialized healthcare provider offering comprehensive obstetrical and gynecological services. Affiliated with the prestigious Brigham & Women's Hospital, the practice occupies a critical niche in the regional healthcare ecosystem. Their service portfolio spans the full spectrum of women's health, from routine prenatal care and gynecologic examinations to complex, minimally invasive surgical interventions. A key differentiator for the firm is its adoption of innovative therapeutic modalities, such as the Sonata Treatment for uterine fibroids, which positions the practice at the forefront of patient-centric, technology-driven care. By maintaining high clinical standards and leveraging its hospital affiliation, the firm effectively captures a significant share of the patient demographic seeking specialized, high-quality medical attention.
How much funding has Brigham/Faulkner Ob/Gyn raised?
Brigham/Faulkner Ob/Gyn has raised a total of $488K across 2 funding rounds:
Debt
$150K
Debt
$338K
Debt (2020): $150K with participation from PPP
Debt (2021): $338K led by PPP
Key Investors in Brigham/Faulkner Ob/Gyn
PPP
Public-Private Partnership
What's next for Brigham/Faulkner Ob/Gyn?
With the recent influx of capital, Brigham/Faulkner Ob/Gyn is well-positioned to accelerate its strategic growth initiatives. Future efforts will likely focus on the expansion of its minimally invasive surgical capabilities and the optimization of patient care pathways through digital health integration. As the practice navigates the complexities of the late-stage growth phase, the focus will remain on maintaining clinical excellence while scaling operations to meet the increasing demand for specialized gynecological services. The organization is expected to prioritize investments in medical infrastructure that enhance diagnostic precision and patient outcomes, further cementing its reputation as a leader in the Boston healthcare landscape. This strategic roadmap ensures that the firm remains resilient against market volatility while continuing to provide essential, high-value medical services to its patient base.
See full Brigham/Faulkner Ob/Gyn company page
